Gain-of-function mutations in SCN9A can produce two distinct inherited pain syndromes: primary erythromelalgia (PE) and paroxysmal extreme pain disorder (PEPD; OMIM #167400). The gene discussed is SCN9A; the disease is paroxysmal extreme pain disorder.